Candel Therapeutics, Inc. (CADL)
5.035
-0.14
(-2.61%)
USD |
NASDAQ |
Mar 18, 15:59
5.055
+0.02
(+0.40%)
After-Hours: 16:47
Candel Therapeutics EPS Diluted (Quarterly) : -0.5373 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.50M |
| Total Expenses (Quarterly) | 29.50M |
| Enterprise Value | 307.99M |
| Earnings Yield | -13.92% |
| Normalized Earnings Yield | -16.10 |